Castres, France

Francis Calmel

This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Calmel. Retrieved from https://idiyas.com/inventor/francis-calmel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Francis Calmel in the Field of Medicinal Chemistry

Introduction

Francis Calmel is a notable inventor based in Castres, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on piperidine derivatives. His research has implications for therapeutic applications, showcasing the intersection of chemistry and medicine.

Latest Patents

Calmel holds a patent for "1,4-disubstituted piperidines, their preparation and their application." This patent includes 1,4-disubstituted piperidines of a specific formula, along with their therapeutically acceptable salts. The invention emphasizes the potential therapeutic applications of these compounds, highlighting their importance in medical treatments.

Career Highlights

Throughout his career, Francis Calmel has been associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical industry. His work has focused on developing innovative compounds that can lead to new therapeutic options for various medical conditions.

Collaborations

Calmel has collaborated with notable colleagues, including Denis Bigg and Jean-Louis Vidaluc. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Francis Calmel's contributions to medicinal chemistry through his patent on piperidine derivatives exemplify the vital role of innovation in healthcare. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…